Shanghai Runda Medical Technology Co Ltd
SSE:603108

Watchlist Manager
Shanghai Runda Medical Technology Co Ltd Logo
Shanghai Runda Medical Technology Co Ltd
SSE:603108
Watchlist
Price: 15.65 CNY 3.3%
Market Cap: 9.4B CNY

Net Margin
Shanghai Runda Medical Technology Co Ltd

-2.1%
Current
2%
Average
1%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-2.1%
=
Net Income
-157.8m
/
Revenue
7.4B

Net Margin Across Competitors

No Stocks Found

Shanghai Runda Medical Technology Co Ltd
Glance View

Shanghai Runda Medical Technology Co Ltd, nestled in the bustling heart of China's economic capital, stands as a quintessential example of a company thriving at the crossroads of innovation and healthcare. Established as a key player in medical diagnostics, Runda Medical focuses on the distribution and provision of high-quality medical devices and diagnostic solutions. Their business model revolves around integrating advanced technology with healthcare needs, enabling medical institutions to enhance their diagnostics capabilities through cutting-edge equipment and robust system support. The company holds a substantial portfolio of both proprietary and partnered products, allowing healthcare providers faster and more precise diagnostic insights. This is bolstered by a dependable supply chain and comprehensive after-sales service, ensuring that medical institutions can rely on consistent performance from their systems. Runda Medical's financial engine is powered predominantly by its distribution networks and strategic partnerships with leading medical technology firms worldwide. By leveraging these alliances, the company can offer a wide range of products that serve various segments of the medical industry, including hospitals, clinics, and laboratories. Revenue flows are primarily generated through the sale of medical devices such as automated analyzers, imaging systems, and diagnostic reagents — all designed to meet the growing demands for efficiency and accuracy in healthcare diagnosis. Moreover, their value proposition is further enhanced by the company's investments in customer education and training, ensuring that the end-users of their systems are not just purchasers but long-term partners in progress, thereby solidifying Runda Medical's reputation as a steadfast ally in China's healthcare landscape.

Intrinsic Value
21.03 CNY
Undervaluation 26%
Intrinsic Value
Price
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-2.1%
=
Net Income
-157.8m
/
Revenue
7.4B
What is the Net Margin of Shanghai Runda Medical Technology Co Ltd?

Based on Shanghai Runda Medical Technology Co Ltd's most recent financial statements, the company has Net Margin of -2.1%.

Back to Top